A Study to Evaluate the Safety and Efficacy of Tazarotene Foam, 0.1%, in Subjects With Common Facial Acne
Public ClinicalTrials.gov record NCT01017120. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Double-Blind, Vehicle-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of Tazarotene Foam, 0.1%, in Subjects With Acne Vulgaris
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to assess safety and efficacy of a new foam formulation of tazarotene in subjects with acne vulgaris.
Study identification
- NCT ID
- NCT01017120
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 742 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 12 Years to 45 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 30, 2009
- Primary completion
- Oct 31, 2010
- Completion
- Nov 8, 2010
- Last update posted
- May 17, 2017
2009 – 2010
United States locations
- U.S. sites
- 14
- U.S. states
- 11
- U.S. cities
- 14
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| The Laser Institute for Dermatology | Santa Monica | California | 90404 | — |
| FXM Research Corporation | Miami | Florida | 33175 | — |
| Atlanta Dermatology & Vein Research Center, PC | Alpharetta | Georgia | 30022 | — |
| Gwinnett Clinical Research Center, Inc. | Snellville | Georgia | 30078 | — |
| Hudson Dermatology | Evansville | Indiana | 47714 | — |
| Dermatology Specialists | Louisville | Kentucky | 40202 | — |
| Henry Ford Medical Center | Detroit | Michigan | 48202 | — |
| Somerset Skin Centre | Troy | Michigan | 48084 | — |
| Skin Specialists, P.C. | Omaha | Nebraska | 68144 | — |
| Dermatology Associates of Rochester, PC | Rochester | New York | 14623 | — |
| Clinical Partners, LLC | Johnston | Rhode Island | 02919 | — |
| Suzanne Bruce and Associates, PA | Houston | Texas | 77056 | — |
| Progressive Clinical Research | San Antonio | Texas | 78229 | — |
| Virginia Clinical Research, Inc. | Norfolk | Virginia | 23507 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 4 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01017120, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 17, 2017 · Synced Sep 10, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01017120 live on ClinicalTrials.gov.